Bio Spectrum - December 2022![ãæ°ã«å
¥ãã«è¿œå Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Bio Spectrum - December 2022![ãæ°ã«å
¥ãã«è¿œå Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Magzter GOLDã§èªã¿æŸé¡ãå©çšãã
1 åã®è³Œèªã§ Bio Spectrum ãš 9,000 ããã³ãã®ä»ã®éèªãæ°èãèªãããšãã§ããŸã  ã«ã¿ãã°ãèŠã
1 ã¶æ $9.99
1 幎$99.99
$8/ã¶æ
ã®ã¿è³Œèªãã Bio Spectrum
1幎$11.88 $7.99
ãã®å·ãè³Œå ¥ $0.99
ãã®åé¡ã§
Can INDIA Dethrone CHINA In API PRODUCTION?
The past decade has witnessed a steady growth and commitment of the Indian government in addressing issues like âself-reliance and self-sufficiencyâ in all aspects of governance and decisions. While sops and subsidies were, indeed, crucial to many concerns of industries and stakeholders, key decisions and schemes were lacking, until numerous âAatmanirbhar Projectsâ were kicked off by the Centre. One such crucial initiative addresses the need for Bulk Drugs Parks in India, making the country less dependent on Chinese Active Pharmaceutical Ingredients (APIs), providing more employment and generating more revenue that will add to the countryâs GDP. A laudable step has been taken with the launching of three Bulk Drugs projects across three states in the country, with an estimated time of completion set at 5 years. We shall take a closer look at what the project entails and seek expert views from a few industry stalwarts.
Bio Spectrum Magazine Description:
åºç瀟: MM Activ Sci-Tech Communication
ã«ããŽãªãŒ: Business
èšèª: English
çºè¡é »åºŠ: Monthly
India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.
ãã€ã§ããã£ã³ã»ã«OK [ å¥çŽäžèŠ ]
ããžã¿ã«ã®ã¿